Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

NEOMED secures $12m from Canadian government NEOMED, a not-for-profit organization whose mission is to create a bridge between academic research and the pharmaceutical industry, will receive $12 million in funding from the Government of Canada to help academic researchers turn their early discoveries into future medicines.
Contract Research & Services > Contract Research > News
Roche's Spring Bioscience introduces PD-L1 IHC antibody for immunotherapy research By PBR Staff Writer
Roche's Spring Bioscience has launched its PD-L1 (SP142) rabbit monoclonal immunohistochemistry (IHC) antibody.
Contract Research & Services > Contract Research > News FDA grants orphan drug status for Insys’ CBD to treat glioblastoma multiforme By PBR Staff Writer
The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Insys Therapeutics' pharmaceutical cannabidiol (CBD) to treat glioblastoma multiforme (GBM).
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
BreedIT, Seach form KanaboSeed to develop new medical cannabis varieties
BreedIT Corp through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide license holder and distributor of highly sophisticated agro-breeding solutions software for plant breeders and researchers, is pleased to announce the formation of KanaboSeed Ltd., a joint venture with Seach Ltd, a leading Israeli medical Cannabis breeder.
Contract Research & Services > Contract Research > News
UK launches emergency research to help battle Ebola outburst
By PBR Staff Writer
The UK Department for International Development (DIFD) and the Wellcome Trust health research charity have offered experts £6.5m to find ways to save the lives of citizens hit with the Ebola virus.
Contract Research & Services > Contract Research > News
Softigel - Manufacturers of Softgel Pharmaceutical Products
Softigel develops and manufactures softgel (soft gelatin) capsules, advanced drug delivery technologies, nutritional supplements, as well as veterinary, cosmetic and pharmaceutical products. Softgels are an effective delivery system for oral drugs, especially those with low solubility and/or permeability (BCS classes II, III and IV). We are Procaps' stategic business division for contract manufacturing services.
Contract Research & Services > Contract Research > Suppliers
Recipharm to buy Corvette Pharmaceutical Services for $160m
By PBR Staff Writer
Swedish contract development and manufacturing organisation Recipharm has agreed to purchase Milan based Corvette Pharmaceutical Services Group (Corvette) from Italian private equity group LBO Italia Investimenti.
Contract Research & Services > Contract Research > News
Clinigen Group acquires Ethyol (amifostine) global rights from AstraZeneca
Clinigen Group, the specialty global pharmaceutical company, announces the acquisition of the global rights to the oncology support therapy, Ethyol (amifostine) from AstraZeneca.
Contract Research & Services > Contract Research > News
Immune Targeting Systems and WCCT Global announce a new influenza A H1N1 virus to support the experimental human viral challenge model
Immune Targeting Systems (ITS), specializing in the development of novel T cell immune therapies, has been developing an exciting new T cell vaccine (FlunisynTM) designed to protect humans from all strains of seasonal and pandemic influenza A.
Contract Research & Services > Contract Research > News
Provectus signs MoU with Sinopharm-CSIPI and Sinopharm A-THINK
Provectus Biopharmaceuticals has entered into a Memorandum of Understanding (MOU) with Sinopharm-China State Institute of Pharmaceutical Industry (Sinopharm-CSIPI), the leader among all pharmaceutical research institutes in China, and Sinopharm A-THINK Pharmaceutical (Sinopharm A-THINK), the only injectable anti-tumor drug research and development, manufacture and distribution integrated platform within Sinopharm Group.
Contract Research & Services > Contract Research > News
PharPoint Research wins project award from Otologic Pharmaceuticals
North Carolina-based CRO, PharPoint Research, has announced their award from Otologic Pharmaceuticals for a full service, Phase I clinical trial assessing the safety, tolerability, and pharmacokinetic profile of agents in the treatment of hearing loss.
Contract Research & Services > Contract Research > News
Reprogenetics expands to Southeast with Miami facility
Reprogenetics, the largest genetics laboratory in the United States specializing in Preimplantation Genetic Screening (PGS), the technique of examining the normal number of chromosomes in embryos, announced the grand opening of its new facility in Miami, Florida.
Contract Research & Services > Contract Research > News
Boehringer acquires licensing rights for Artilysin technology from Lysando
Artilysin, a new and innovative technological approach in the fight against pathogenic and multi-resistant bacteria, developed by the research & development company Lysando, has arrived in the pharmaceutical industry.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250